733 / 1119
3
With dose optimisation in a small
tumour...
1.
Point A dose
becomes typically
higher
2.
HR CTV D90
becomes typically
higher
3.
OAR dose becomes
typically lower
|
|
733 / 1119
3
With dose optimisation in a small
tumour...
1.
Point A dose
becomes typically
higher
2.
HR CTV D90
becomes typically
higher
3.
OAR dose becomes
typically lower